Skip to main content
NIH funding notice RFA-AG-22-016

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required)

Closed on September 15, 2021.

Posted
April 6, 2021
Close date
September 15, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,626,368 in first-year total cost, median $371,433.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-D (M1)]5

Most frequent institutions

  1. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
  2. KAISER FOUNDATION RESEARCH INSTITUTE1
  3. PENNSYLVANIA STATE UNIV HERSHEY MED CTR1
  4. UNIVERSITY OF IOWA1
  5. UNIVERSITY OF KANSAS MEDICAL CENTER1
Competing awards under RFA-AG-22-016 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022De Pié y a Movernos Study: Promoting physical activity in older Latinx adults1R61AG077969-01ROSENBERG, DORI EZLATAR, ZVINKA ZOEKAISER FOUNDATION RESEARCH INSTITUTE, CA$376,244ZAG1
2022Guided Episodic Future Thinking to Increase Physical Activity Adherence and Promote Healthy Brain Aging Among Mid-Life Adults1R61AG078087-01MARTIN, LAURA EUNIVERSITY OF KANSAS MEDICAL CENTER, KS$372,484ZAG1
2022Mechanisms of Adherence to Light Intensity Physical Activity to Prevent Alzheimer's Disease and Related Dementias1R61AG078084-01HAKUN, JONATHAN G.PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA$371,433ZAG1
2022Targeting Cognitive Control to Improve Physical Activity Adherence in Midlife for Alzheimer's Risk Reduction1R61AG078041-01VOSS, MICHELLE WEBBUNIVERSITY OF IOWA, IA$348,416ZAG1
2022Goal Setting to Promote Physical Activity Adherence in Midlife to Reduce Risk of Alzheimer's Disease and Related-Dementias: A Randomized Mechanistic Proof-of-Concept Trial1R61AG078089-01JOSEPH, RODNEYMAXFIELD, MOLLYARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ$157,791ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-22-016: Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) | ScienceDex | ConductScience